Amy Sarah Ginsburg

Summary

Publications

  1. ncbi request reprint Diagnosis of pediatric human immunodeficiency virus infection in resource-constrained settings
    Amy Sarah Ginsburg
    Elizabeth Glaser Pediatric AIDS Foundation, Santa Monica, CA 90405, USA
    Pediatr Infect Dis J 25:1057-64. 2006
  2. ncbi request reprint Provision of care following prevention of mother-to-child HIV transmission services in resource-limited settings
    Amy Sarah Ginsburg
    Elizabeth Glaser Pediatric AIDS Foundation, Santa Monica, CA, USA
    AIDS 21:2529-32. 2007
  3. pmc Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system
    Amy Sarah Ginsburg
    Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Antimicrob Agents Chemother 49:853-6. 2005

Detail Information

Publications3

  1. ncbi request reprint Diagnosis of pediatric human immunodeficiency virus infection in resource-constrained settings
    Amy Sarah Ginsburg
    Elizabeth Glaser Pediatric AIDS Foundation, Santa Monica, CA 90405, USA
    Pediatr Infect Dis J 25:1057-64. 2006
    ..Antibody testing provides a definitive diagnosis in older children but is frequently not used. Children meeting clinical criteria should be treated regardless of availability of laboratory diagnoses...
  2. ncbi request reprint Provision of care following prevention of mother-to-child HIV transmission services in resource-limited settings
    Amy Sarah Ginsburg
    Elizabeth Glaser Pediatric AIDS Foundation, Santa Monica, CA, USA
    AIDS 21:2529-32. 2007
    ..To evaluate the provision of care for mother and child after institution of prevention of mother-to-child transmission (PMTCT) of HIV services...
  3. pmc Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system
    Amy Sarah Ginsburg
    Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Antimicrob Agents Chemother 49:853-6. 2005
    ..We found this system to be a robust method for modeling in vivo pharmacokinetics and present data supporting the utility of intermittent moxifloxacin treatment as a component of antituberculosis chemotherapy...